Neonatal screening for inborn errors of metabolism: cost, yield and outcome.

• 1 January 1997
• journal article
• review article
• Published by National Institute for Health and Care Research in Health Technology Assessment
• Vol. 1  (7)
• https://doi.org/10.3310/hta1070

Abstract

Keywords

• CYSTIC FIBROSIS
• ORGANIC ACID
• ECONOMIC EVALUATIONS
• COSTS AND BENEFITS
• ADDITIONAL CASE
• COST PER ADDITIONAL
• NEONATAL SCREENING TECHNOLOGY

Funding Information

• Health Technology Assessment Programme (93/36/01)